Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Monthly Archives: February 2012
FDA adds 2 makers of cancer drugs
Posted: Published on February 22nd, 2012
TRENTON, N.J. -- Federal regulators have approved new suppliers for two crucial cancer drugs, easing critical shortages that had been ratcheting up fears that patients, particularly children with leukemia, would miss lifesaving treatments. But there are currently 283 separate prescription drugs in short supply or unavailable nationwide, and regulators and manufacturers say shortages are a long-term problem that will continue to give patients and doctors nightmares. On Tuesday, the Food and Drug Administration said it will temporarily allow importation of a replacement drug for Doxil, a drug for recurrent ovarian or bone marrow cancer. The Johnson & Johnson drug hasn't been available for new patients for months because J&J's contract manufacturer had to shut down production over serious quality lapses. The FDA also has approved a new supplier for a preservative-free version of methotrexate, a crucial drug for children with a type of leukemia called ALL, for lymphomas and for the bone cancer osteosarcoma. The version with preservatives, the one that's been scarce, can be toxic or cause paralysis in children and other patients getting the drug either by injections into spinal cord fluid or at very high doses. The FDA also has approved the release of a batch manufactured … Continue reading
Posted in Drugs
Comments Off on FDA adds 2 makers of cancer drugs
The Philippine Society Of Hospital Pharmacists' 50th Anniversary And Annual Convention At The Historic Landmark Manila …
Posted: Published on February 22nd, 2012
MANILA, Philippines - Hospital pharmacy forms an integral part of patient health care. Over the years, the profession has endeavored to maintain and improve the medication management and pharmaceutical care of patients at the highest standards in a hospital setting. From just compounding and dispensing of medications, hospital pharmacists have evolved into be patient-focused professionals collaborating with doctors, nurses, and other allied health workers. They are now providing medication counseling, ensuring medication safety, promoting appropriate use of medications, monitoring adverse drug reactions, and reconciling patient medication orders and history. These new roles pose a challenge to the pharmacists of today who need continuous learning, training and education, and networking. The Philippine Society of Hospital Pharmacists (PSHP) is a nationwide organization of hospital pharmacists with the mission to promote safe and effective use of medication by enhancing the competence of its members and by collaborating with other healthcare professionals and allied organizations to improve the health and wellbeing of patients. In the last 50 years, the PSHP has been involved in supporting and providing the needs of hospital pharmacists through training and education, outreach programs, and giving scholarship grants. The PSHP developed a comprehensive Clinical Pharmacy Training Program in cooperation with … Continue reading
Posted in Pharmacy
Comments Off on The Philippine Society Of Hospital Pharmacists' 50th Anniversary And Annual Convention At The Historic Landmark Manila …
Footsteps fail to keep pace with Pharmacy
Posted: Published on February 22nd, 2012
EAST Griffith Pharmacy has stormed through to the Griffith women’s division one touch football final, after a clinical display against Footsteps Podiatry on Monday night. Try as they might, Footsteps were unable to penetrate Pharmacy’s defence which repelled many attacking waves as they went about setting up an unassailable lead. With a storm before the start of play, the handling by both sides was above what could be expected with Madeline Lyons looking dangerous with ball in hand early for Pharmacy. Lyons was the first to put her side on the board when she made the most of a gap close to the ruck, to scoot away from the incoming defence. Turnovers in both team’s half began to creep into the game, but Pharmacy made the most of its attacking opportunities, doubling its lead. The lead crept out to three when Eliza Baddock sold a good dummy-pass before finding Sarah Mannell for the touchdown, with the girls in pink taking the three-try lead into the break. Footsteps needed to be the first to score after the resumption if they were to have a chance of climbing back into the game, but it was the front-runners that extended the lead as … Continue reading
Posted in Pharmacy
Comments Off on Footsteps fail to keep pace with Pharmacy
CVS Pharmacy: prescription for contaminated site
Posted: Published on February 22nd, 2012
Read more: Local, Economy, Business, Community, Environment, New CVS Pharmacy on the Corner of Front Street and Division in Traverse City, CVS Pharmacy, Front Street and Division Street, Traverse City Commissioners, Traverse City Commission, Jim Carruthers Traverse City Commission, CVS Zoning Change Approved TRAVERSE CITY -- Plans for a new CVS Pharmacy on the corner of Front Street and Division in Traverse City were given the go ahead Tuesday night by City Commissioners. Commissioners voted to change the area from a C-2 zone to a C-3, making the area a Community Center District, which allows the pharmacy to include a drive-thru window, driveway, and parking lot. The site has been vacant for nearly 20 years and is considered one of the most contaminated areas in Traverse City. Commissioners hope this new development will provide the clean-up, that is long overdue. Traverse City Commissioner Jim Carruthers says,"it's an ugly spot.. it looks bad. This is kind of the gateway to our town, this is one of the larger traffic corridors of the city. There's been a concerned with how it looks, so a tax capture will help kick-in some clean up dollars, environmental clean up dollars, that could be considered a positive." Commissioners say … Continue reading
Posted in Pharmacy
Comments Off on CVS Pharmacy: prescription for contaminated site
Sebastopol council rejects CVS Pharmacy design
Posted: Published on February 22nd, 2012
Published: Tuesday, February 21, 2012 at 3:00 a.m. Last Modified: Tuesday, February 21, 2012 at 10:57 p.m. The Sebastopol City Council reaffirmed its denial of the proposed CVS Pharmacy project Tuesday night, finding the project was out of sync with the city’s Main Street character. The council adopted a series of suggestions for design changes, should the developer decide to continue with the project. It recommended a litany of changes, including solar, larger windows and less parking. In a 3-2 vote, the council upheld the Design Review Board ruling against the design by the developer, Armstrong Development of Sacramento, which could send the project back to the drawing board. “I hope you take this back to the Design Review,” said Councilwoman Kathleen Shaffer. “I think you will be treated fairly and some resolution can be reached.” Shaffer, a supporter of the CVS project, and Councilman Patrick Slayter were the two votes on Armstrong’s behalf. Mayor Guy Wilson, Vice Mayor Mike Kyes and Councilwoman Sarah Gurney voted to uphold the Design Review Board. Bill McDermott, vice president for Armstrong, said he will take the council’s action and suggestions back to CVS before a decision is made whether to continue with the … Continue reading
Posted in Pharmacy
Comments Off on Sebastopol council rejects CVS Pharmacy design
Adult Stem Cell Treatments for COPD – Real patient results, USA Stem Cells – Marian H. Testimonial – Video
Posted: Published on February 21st, 2012
20-12-2011 08:50 If you would like more information please call us Toll Free at 877-578-7908. Or visit our website at http://www.usastemcells.com Or click here to have a Free Phone Constultation with Dr. Matthew Burks usastemcells.com Real patient testimonials for USA Stem Cells. Adult stem cell therapy for COPD, Emphysema, and Pulmonary fibrosis. Continued here: Adult Stem Cell Treatments for COPD - Real patient results, USA Stem Cells - Marian H. Testimonial - Video … Continue reading
Posted in Mesenchymal Stem Cells
Comments Off on Adult Stem Cell Treatments for COPD – Real patient results, USA Stem Cells – Marian H. Testimonial – Video
Adult Stem Cell Treatments for COPD -Real patient results, USA Stem Cells- Shirlen M. Testimonial – Video
Posted: Published on February 21st, 2012
11-01-2012 23:04 If you would like more information please call us Toll Free at 877-578-7908. Or visit our website at http://www.usastemcells.com Or click here to have a Free Phone Constultation with Dr. Matthew Burks usastemcells.com Real patient testimonials for USA Stem Cells. Adult stem cell therapy for COPD, Emphysema, and Pulmonary fibrosis. Read the original post: Adult Stem Cell Treatments for COPD -Real patient results, USA Stem Cells- Shirlen M. Testimonial - Video … Continue reading
Posted in Mesenchymal Stem Cells
Comments Off on Adult Stem Cell Treatments for COPD -Real patient results, USA Stem Cells- Shirlen M. Testimonial – Video
medi-post.wmv – Video
Posted: Published on February 21st, 2012
28-01-2012 00:47 Care for Patients, Innovations from Research" Making better quality living within reach MEDIPOST is a leading stem cell biotechnology company focused on developing products to meet unmet medical needs such as those related to regenerative or functional recovery of knee articular cartilage, the nervous system, the pulmonary system and hematopoietic transplantation engraftment areas. Revolutionizing medical care MEDIPOST provides services and develops products related to a readily available and non-controversial source - human umbilical cord blood and human Umbilical Cord Blood derived Mesenchymal Stem Cells (hUCB-MSCs), respectively. The stem cells, coming from unrelated healthy donors, have demonstrated the ability to regenerate and/or to recover functionality of different types of damaged tissues. Such adult stem cell therapies having an "off-the-shelf" concept revolutionize medical treatments and are bringing about a new era of mass-manufactured allogeneic stem cell drug products. Read the rest here: medi-post.wmv - Video … Continue reading
Posted in Mesenchymal Stem Cells
Comments Off on medi-post.wmv – Video
Ligand Licenses DARA Program to Retrophin
Posted: Published on February 21st, 2012
SAN DIEGO & NEW YORK--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND - News) and Retrophin, LLC announced that the companies have entered into an agreement in which Ligand has licensed rights to DARA (a Dual Acting Receptor Antagonist of Angiotensin and Endothelin receptors) to Retrophin. Under the terms of the agreement, Ligand will receive a net upfront payment of $1 million, and may receive, net of amounts owed to third parties, over $75 million in milestone payments based on clinical and regulatory progress as well as 9% in royalties on potential future worldwide sales by Retrophin. “DARA has the promise to be a significant medicine, and we are excited to partner with Retrophin to advance the development of the program and bring it closer to patients in need,” said John Higgins, President and Chief Executive Officer of Ligand Pharmaceuticals. “This is an attractive deal for Ligand and our shareholders. We have partnered DARA with a team that has great credentials, is highly motivated to advance the program and has a compelling development plan. This is another valuable asset in our late-stage portfolio.” Retrophin intends to develop DARA for orphan indications of severe kidney diseases including Focal Segmental Glomerulosclerosis (FSGS) as well as conduct proof-of-concept studies … Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Ligand Licenses DARA Program to Retrophin
Cure Duchenne Announces Three New Funded Research Projects to Help Develop Treatments and Find a Cure for Duchenne …
Posted: Published on February 21st, 2012
Newport Beach, Calif., Feb. 21, 2012 (GLOBE NEWSWIRE) -- CureDuchenne, a nonprofit organization that raises awareness and funds multiple research and development projects to cure Duchenne muscular dystrophy, announces the funding of three new research projects following its third annual CureDuchenne Scientific Summit. CureDuchenne is dedicated to finding treatments and a cure for Duchenne regardless of the specific genetic mutation by advancing drug development programs, identifying new drug targets that exhibit potential to transform the treatment of Duchenne and help drive the most promising research programs to market. CureDuchenne's comprehensive research portfolio now funds three new projects that includes development of a new MDX mouse model with duplicated exons, a study with currently approved drugs that may help treat critical cardiac issues and also supports the reformulation of the utrophin upregulator SMT C1100. "CureDuchenne takes a comprehensive and strategic approach to the projects we fund," said Debra Miller, founder and CEO of CureDuchenne. "Every Duchenne child is important so we are funding three promising research projects that address a variety of mutations and could lead to better treatments and hope for Duchenne families." MDX Mouse Model There is currently no animal model with a Duchenne muscular dystrophy duplication and this … Continue reading
Posted in Muscular Dystrophy Treatment
Comments Off on Cure Duchenne Announces Three New Funded Research Projects to Help Develop Treatments and Find a Cure for Duchenne …